SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-019930
Filing Date
2019-10-08
Accepted
2019-10-08 06:01:48
Documents
3
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k100719_biondvaxpharma.htm 6-K 10569
2 PRESS RELEASE DATED OCTOBER 7, 2019 f6k100719ex99-1_biondvax.htm EX-99.1 9491
3 GRAPHIC image_004.jpg GRAPHIC 7555
  Complete submission text file 0001213900-19-019930.txt   31597
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 191141780
SIC: 2836 Biological Products, (No Diagnostic Substances)